Literature DB >> 1544516

MRI of the brain, EEG sleep spindles and SPECT in the early diagnosis of infantile neuronal ceroid lipofuscinosis.

P Santavuori1, R Raininko, S L Vanhanen, J Launes, K Sainio.   

Abstract

Two patients with infantile neuronal ceroid lipofuscinosis are presented whose clinical diagnosis was based on the typical clinical picture, together with absent sleep spindles and MRI findings (hypointense thalami and hyperintense periventricular white matter) as early as 18 months in one girl. In addition to a flat cortical SEP, these abnormalities appeared earlier than the typical ERG and VEP findings used previously for clinical diagnosis of this condition. MRI of the other patient showed the same changes and EEG sleep spindles were absent by two years.

Entities:  

Mesh:

Year:  1992        PMID: 1544516     DOI: 10.1111/j.1469-8749.1992.tb08564.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.

Authors:  Sondra W Levin; Eva H Baker; Wadih M Zein; Zhongjian Zhang; Zenaide M N Quezado; Ning Miao; Andrea Gropman; Kurt J Griffin; Simona Bianconi; Goutam Chandra; Omar I Khan; Rafael C Caruso; Aiyi Liu; Anil B Mukherjee
Journal:  Lancet Neurol       Date:  2014-07-02       Impact factor: 44.182

Review 2.  Infantile neuronal ceroid-lipofuscinosis (INCL): diagnostic criteria.

Authors:  P Santavuori; S L Vanhanen; K Sainio; M Nieminen; T Wallden; J Launes; R Raininko
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Visual behaviours of neurologically impaired children with cerebral visual impairment: an ethological study.

Authors:  G Porro; E M Dekker; O Van Nieuwenhuizen; D Wittebol-Post; M B Schilder; A J Schenk-Rootlieb; W F Treffers
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

Review 4.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.